A rationally designed anticancer drug targeting a unique binding cavity of tubulin. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

A rationally designed anticancer drug targeting a unique binding cavity of tubulin.

Uckun FM, Mao C, Vassilev AO, Navara CS, Narla RK, Jan ST. A rationally designed anticancer drug targeting a unique binding cavity of tubulin. Bioorg Med Chem Lett. 2000 May 15; 10(10):1015-8.

View in: PubMed

authors with profiles

Christopher Navara

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support